levonorgestrel has been researched along with Weight Loss in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alizart, M; Armes, JE; Chen, C; Chetty, N; Cummings, M; Eva, L; Garrett, A; Gebski, V; Hoet, G; Janda, M; Land, R; Leung, Y; McNally, O; Nicklin, JL; Obermair, A; Oehler, MK; Perrin, LC; Robledo, KP; Sowden, K; Sykes, P; Tang, A; Tristram, A; Walker, G | 1 |
| Mayeda, ER; Torgal, AH; Westhoff, CL | 1 |
| Armes, J; Brennan, D; Gebski, V; Hawkes, AL; Janda, M; Obermair, A; Quinn, M | 1 |
| Cansino, C; Curtis, KM; Jamieson, DJ; Paulen, ME; Zapata, LB | 1 |
| Shittu, O; Sule, S | 1 |
1 review(s) available for levonorgestrel and Weight Loss
| Article | Year |
|---|---|
Contraceptive use among women with a history of bariatric surgery: a systematic review.
Topics: Bariatric Surgery; Contraceptives, Oral; Female; Gastric Bypass; Gastroplasty; Humans; Levonorgestrel; Obesity; Pregnancy; PubMed; Weight Loss | 2010 |
3 trial(s) available for levonorgestrel and Weight Loss
| Article | Year |
|---|---|
Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial.
Topics: Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metformin; Middle Aged; Neoplasm Staging; Weight Loss; Weight Reduction Programs | 2021 |
Weight and body composition changes during oral contraceptive use in obese and normal weight women.
Topics: Adult; Body Composition; Body Mass Index; Contraceptives, Oral; Dose-Response Relationship, Drug; Electric Impedance; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Obesity; Outcome Assessment, Health Care; Prospective Studies; Time Factors; Weight Gain; Weight Loss; Young Adult | 2014 |
Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device ± metformin ± weight loss in endometrial cancer (feMME) trial.
Topics: Adenocarcinoma; Biomarkers, Tumor; Diet; Endometrial Neoplasms; Exercise; Female; Humans; Intrauterine Devices; Levonorgestrel; Metformin; Neoplasm Staging; Obesity; Prospective Studies; Research Design; Weight Loss | 2014 |
1 other study(ies) available for levonorgestrel and Weight Loss
| Article | Year |
|---|---|
Weight changes in clients on hormonal contraceptives in Zaria, Nigeria.
Topics: Adult; Body Weight; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Retrospective Studies; Weight Gain; Weight Loss | 2005 |